WeInfuse Unites With NICA Against CMS’s Cuts to Average Sales Price for Cimzia and Orencia
WeInfuse Unites With NICA Against CMS's Cuts to Average Sales Price for Cimzia and Orencia Voicing Our Concerns for [...]
WeInfuse Unites With NICA Against CMS's Cuts to Average Sales Price for Cimzia and Orencia Voicing Our Concerns for [...]
WeInfuse joins the National Infusion Center Association and infusion providers across the country to voice our deep concern and opposition to the new [...]
Site of Care (SOC) Optimization is one of the top proven strategies for reducing the cost of specialty biologic medications. A SOC optimization strategy encourages patients to move from higher-cost settings, like big hospitals and institutions, to lower-cost settings, such as physician’s in-office infusion suites or stand-alone Infusion Centers.
At WeInfuse, we think the annual Magellan Trend Reports are our industry’s manna from heaven. This year’s 2018 report is no different, and it’s full of gold nuggets that prove the provider-based (e.g. physician, NP, and/or PA) Infusion Center is the optimal site of service providing patients quality, convenient and cost-effective care.
Listen to our recently launched WeInfuse Infusion Center Podcast series to hear interviews from infusion suite and Infusion Center industry experts. Learn how some of the leading [...]